• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮中的补体成分、C1激活与疾病活动度

Complement components, C1 activation and disease activity in SLE.

作者信息

Sturfelt G, Sjöholm A G, Svensson B

出版信息

Int Arch Allergy Appl Immunol. 1983;70(1):12-8. doi: 10.1159/000233266.

DOI:10.1159/000233266
PMID:6293980
Abstract

Laboratory parameters were studied in 8 systemic lupus erythematosus patients during periods of high and low disease activity, mainly as defined by clinical criteria. Renal manifestations were present in 6 patients 5 of which showed antibodies to native DNA. C-reactive protein was raised in 3 patients. Only 1 of these showed a superimposed bacterial infection. Markedly high concentrations of C1r-C1s-C1 inactivator cOmplexes (C1r-C1s-Cl IA) in the sera provided direct evidence of C1 activation independent of disease activity. During active disease. C1r-C1s-C1 IA were correlated with C1q binding immune complexes as measured by solid phase, but not by fluid phase assay. Immunochemical concentrations of C1q, C4 and C3 and functional C2 were decreased in active SLE, consistent with sequential activation of the classical pathway. Discrepancies were noted between functional and immunochemical assay for C2 but not for factor B. Although essentially within the normal range, the levels of C1s, C4 binding protein, C5 and properdin were lower during active than during inactive disease. The concentrations of the factors B, I and H did not suggest involvement of the alternative pathway. 1 exceptional patient showed low factor B, a relative decrease of factor I and the presence of Bb fragments in plasma during active SLE. Markedly high factor D values were found. This could partly be explained by reduced renal function.

摘要

在8例系统性红斑狼疮患者疾病活动度高和低的时期研究了实验室参数,主要根据临床标准来定义。6例患者有肾脏表现,其中5例显示抗天然DNA抗体。3例患者C反应蛋白升高。其中仅1例有叠加的细菌感染。血清中C1r - C1s - C1灭活剂复合物(C1r - C1s - Cl IA)浓度显著升高,提供了与疾病活动度无关的C1激活的直接证据。在疾病活动期,固相法检测显示C1r - C1s - C1 IA与C1q结合免疫复合物相关,但液相法检测不相关。活动性系统性红斑狼疮患者中,C1q、C4和C3的免疫化学浓度以及功能性C2降低,这与经典途径的顺序激活一致。C2的功能检测和免疫化学检测之间存在差异,但因子B不存在这种差异。虽然基本上在正常范围内,但C1s、C4结合蛋白、C5和备解素的水平在活动期低于非活动期。因子B、I和H的浓度未提示替代途径参与。1例特殊患者在活动性系统性红斑狼疮期间显示因子B低、因子I相对降低以及血浆中存在Bb片段。发现因子D值显著升高。这部分可以通过肾功能降低来解释。

相似文献

1
Complement components, C1 activation and disease activity in SLE.系统性红斑狼疮中的补体成分、C1激活与疾病活动度
Int Arch Allergy Appl Immunol. 1983;70(1):12-8. doi: 10.1159/000233266.
2
Complement components, complement activation, and acute phase response in systemic lupus erythematosus.系统性红斑狼疮中的补体成分、补体激活及急性期反应
Int Arch Allergy Appl Immunol. 1984;75(1):75-83. doi: 10.1159/000233593.
3
Prospective analysis of C1 dissociation and complement activation in patients with systemic lupus erythematosus.系统性红斑狼疮患者C1解离与补体激活的前瞻性分析。
Clin Exp Rheumatol. 1995 Sep-Oct;13(5):573-80.
4
Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.C1的非抗体依赖性激活。二、补体经典途径两类非免疫激活剂的证据。
J Immunol. 1987 Mar 15;138(6):1871-6.
5
C1 subcomponent complexes and C2 cleavage in active systemic lupus erythematosus.活动性系统性红斑狼疮中的C1亚成分复合物与C2裂解
Complement Inflamm. 1991;8(1):1-12. doi: 10.1159/000463172.
6
Sequential studies of complement activation in systemic lupus erythematosus.系统性红斑狼疮补体激活的序贯研究。
Scand J Rheumatol. 1985;14(2):184-96. doi: 10.3109/03009748509165503.
7
C1 subcomponent complexes: basic and clinical aspects.C1亚成分复合物:基础与临床方面
Behring Inst Mitt. 1993 Dec(93):292-8.
8
C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.在类风湿性关节炎患者的滑液中,C1激活,且C1q超过功能性C1。
Int Arch Allergy Appl Immunol. 1986;79(2):113-9. doi: 10.1159/000233956.
9
Circulating immune complexes and C1 activation in patients with rapidly progressive glomerulonephritis, before and after treatment with immunosuppression and plasma exchange.
Int Arch Allergy Appl Immunol. 1983;72(1):9-15. doi: 10.1159/000234833.
10
Antibody-independent activation of C1. I. Differences in the mechanism of C1 activation by nonimmune activators and by immune complexes: C1r-independent activation of C1s by cardiolipin vesicles.补体C1的非抗体依赖性激活。I. 非免疫激活剂和免疫复合物激活C1的机制差异:心磷脂囊泡对C1s的非C1r依赖性激活
J Immunol. 1987 Mar 15;138(6):1864-70.

引用本文的文献

1
Complement as a Therapeutic Target in Systemic Autoimmune Diseases.补体作为系统性自身免疫性疾病的治疗靶点。
Cells. 2021 Jan 13;10(1):148. doi: 10.3390/cells10010148.
2
Complement in the immunopathogenesis of rheumatic disease.补体在风湿性疾病发病机制中的作用。
Nat Rev Rheumatol. 2012 Aug;8(8):458-68. doi: 10.1038/nrrheum.2012.75. Epub 2012 Jun 5.
3
Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays.采用重组抗体微阵列技术对系统性红斑狼疮和系统性硬皮病的血清蛋白谱进行分析。
Mol Cell Proteomics. 2011 May;10(5):M110.005033. doi: 10.1074/mcp.M110.005033. Epub 2011 Feb 24.
4
Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2.补体C4通过一种独立于补体受体CR1和CR2的机制抑制全身性自身免疫。
J Exp Med. 2000 Nov 6;192(9):1339-52. doi: 10.1084/jem.192.9.1339.
5
Terminal complement complexes and C1/C1 inhibitor complexes in autoimmune thyroid disease.自身免疫性甲状腺疾病中的终末补体复合物和C1/C1抑制剂复合物
Clin Exp Immunol. 1989 Jul;77(1):25-30.
6
Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.类风湿关节炎及其他关节炎病症中的终末补体复合物和C1/C1抑制剂复合物
Clin Exp Immunol. 1991 May;84(2):250-5.